Overview Fundamentals API Earnings EOD API Sample Code Pricing

Travere Therapeutics Inc (TVTX NASDAQ) stock market data APIs

$10.8 -0.18(-1.6%) as of September 6, 2024
Price chart is built with Anychart

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Travere Therapeutics Inc Financial Data Overview

10.98
10.8
-
11.91
10.64
5.12-14.62
840 M
76 492 K
178 M
-0.91
0.712
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TVTX',
Type: 'Common Stock',
Name: 'Travere Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000P9D6W9',
ISIN: NULL,
CUSIP: NULL,
CIK: '1438533',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2012-11-08',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Travere Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 178 M
  • EBITDA -275 060 000
  • Earnings Per Share -4.98
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Travere Therapeutics Inc Earnings via APIs

  • Latest Release 2024-08-01
  • EPS/Forecast -0.86

Get Travere Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com